Dipraglurant
Overview[edit]
Dipraglurant is a novel pharmaceutical compound that acts as a selective negative allosteric modulator of the metabotropic glutamate receptor 5 (mGluR5). It is primarily being investigated for its potential therapeutic effects in treating Parkinson's disease and dystonia.
Mechanism of Action[edit]
Dipraglurant functions by modulating the activity of mGluR5, a receptor that plays a significant role in the central nervous system. By inhibiting the overactivity of this receptor, dipraglurant may help alleviate symptoms associated with neurological disorders such as Parkinson's disease.
Clinical Applications[edit]
Parkinson's Disease[edit]
In Parkinson's disease, dipraglurant is being studied for its ability to reduce levodopa-induced dyskinesia, a common side effect of long-term levodopa therapy. By targeting mGluR5, dipraglurant may help improve motor control and reduce involuntary movements.
Dystonia[edit]
Dipraglurant is also under investigation for its potential to treat dystonia, a movement disorder characterized by sustained muscle contractions. The modulation of mGluR5 activity may help in reducing the severity of muscle contractions and improving quality of life for patients.
Pharmacokinetics[edit]
Dipraglurant is administered orally and undergoes hepatic metabolism. Its pharmacokinetic profile is characterized by rapid absorption and a moderate half-life, allowing for convenient dosing schedules.
Development and Research[edit]
Dipraglurant is currently in various stages of clinical trials. Ongoing research aims to further elucidate its efficacy and safety profile in treating neurological disorders.
Related Pages[edit]
Gallery[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
